Sanofi-Aventis weight-loss drug may trigger suicidal behavior: FDA

Stephen McGuire

June 11 2007

The FDA said Monday that Sanofi-Aventis’ weight-loss drug Acomplia (rimonabant) may trigger suicidal behavior and other psychological side effects in ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.